Stephen From - Net Worth and Insider Trading
Stephen From Net Worth
The estimated net worth of Stephen From is at least $691 dollars as of 2024-11-13. Stephen From is the President and CEO of Kiora Pharmaceuticals Inc and owns about 191 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $691. Details can be seen in Stephen From's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen From has not made any transactions after 2019-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen From
Stephen From Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen From owns 1 companies in total, including Kiora Pharmaceuticals Inc (KPRX) .
Click here to see the complete history of Stephen From’s form 4 insider trades.
Insider Ownership Summary of Stephen From
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2019-11-05 | director & President and CEO |
Stephen From Latest Holdings Summary
Stephen From currently owns a total of 1 stock. Stephen From owns 191 shares of Kiora Pharmaceuticals Inc (KPRX) as of July 15, 2019, with a value of $691.
Latest Holdings of Stephen From
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2019-07-15 | 191 | 3.62 | 691 |
Holding Weightings of Stephen From
Stephen From Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen From has made a total of 0 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years. The most-recent trade in Kiora Pharmaceuticals Inc is the sale of 24 shares on July 15, 2019, which brought Stephen From around $30,565.
Insider Trading History of Stephen From
- 1
Stephen From Trading Performance
GuruFocus tracks the stock performance after each of Stephen From's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen From is 13.56%. GuruFocus also compares Stephen From's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen From within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen From's insider trading performs compared to the benchmark.
Performance of Stephen From
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.06 | | | | | |
| Relative Return to S&P 500(%) | 12.92 | | | | | |
Stephen From Ownership Network
Ownership Network List of Stephen From
Ownership Network Relation of Stephen From
Stephen From Owned Company Details
What does Kiora Pharmaceuticals Inc do?
Who are the key executives at Kiora Pharmaceuticals Inc?
Stephen From is the director & President and CEO of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Chief Development Officer Eric Joseph Daniels , and director & President and CEO Brian M. Strem .
Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary
Over the past 18 months, Stephen From made no insider transaction in Kiora Pharmaceuticals Inc (KPRX). Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .
In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 12,500 shares, with a net purchase of 12,500 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.
Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiora Pharmaceuticals Inc Insider Transactions
Stephen From Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen From. You might contact Stephen From via mailing address: C/o Burns & Levinson Llp, 125 Summer Street, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
